MAPT and Alzheimer disease: Notably, tau phosphorylation at Thr231 and other nearby residues negates Bin1 SH3 binding, precluding normal binding and enabling accumulation and aggregation of hyperphosphorylated tau that causes AD pathophysiology (Sottejeau et al., 2015).